![Frédéric Grégoire René Sedel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Frédéric Grégoire René Sedel is the founder of MedDay Pharmaceuticals SA, founded in 2011, where the title held is Chief Scientific Officer & Director since 2018.
The current job is General Manager & Chief Medical Officer at OTR3, starting in 2021.
Aktive Positionen von Frédéric Grégoire René Sedel
| Unternehmen | Position | Beginn |
|---|---|---|
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology Operates as a biotechnology company developing new drugs for nervous system disorders | Gründer | 29.09.2011 |
OTR3
 OTR3 BiotechnologyHealth Technology Operates biotechnology company | Vorstandsvorsitzender | 01.07.2021 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
10
Beziehungen ersten Grades
2
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology Operates as a biotechnology company developing new drugs for nervous system disorders | Health Technology |
OTR3
OTR3 BiotechnologyHealth Technology Operates biotechnology company | Health Technology |
